BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5775069)

  • 1. The rate of absorption and duration of action of four different solutions of methyl nicotinate.
    Fountain RB; Baker BS; Hadgraft JW; Sarkany I
    Br J Dermatol; 1969 Mar; 81(3):202-6. PubMed ID: 5775069
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of glycerol on the percutaneous absorption of methyl nicotinate.
    Hadgraft J; Hadgraft JW; Sarkany I
    Br J Dermatol; 1972 Jul; 87(1):30-6. PubMed ID: 5043196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the permeability of human skin to nicotinic acid, methyl nicotinate and butyl nicotinate. -- with emphasis on the influence of liquid vehicles and that of water immersion (author's transl)].
    Matushima I; Osamura H
    Nihon Hifuka Gakkai Zasshi; 1980 Jul; 90(8):687-99. PubMed ID: 6971347
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninvasive assessments of the percutaneous absorption of methyl nicotinate in humans.
    Guy RH; Wester RC; Tur E; Maibach HI
    J Pharm Sci; 1983 Sep; 72(9):1077-9. PubMed ID: 6631699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeation, metabolism and site of action concentration of nicotinic acid derivatives in human skin. Correlation with topical pharmacological effect.
    Müller B; Kasper M; Surber C; Imanidis G
    Eur J Pharm Sci; 2003 Oct; 20(2):181-95. PubMed ID: 14550884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents.
    Remane Y; Leopold CS
    Skin Pharmacol Physiol; 2006; 19(6):303-10. PubMed ID: 16931897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous absorption: in vivo experiments.
    Albery WJ; Hadgraft J
    J Pharm Pharmacol; 1979 Mar; 31(3):140-7. PubMed ID: 34686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin penetration of nicotinic acid, methyl nicotinate, and butyl nicotinate in the guinea pig--comparison of in vivo and excised skin, and the effects of four dermatologic conditions.
    Osamura H; Jimbo Y; Ishihara M
    J Dermatol; 1984 Oct; 11(5):471-81. PubMed ID: 6397492
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between percutaneous penetration of methyl nicotinate and sensitive skin, using laser Doppler imaging.
    Issachar N; Gall Y; Borrel MT; Poelman MC
    Contact Dermatitis; 1998 Oct; 39(4):182-6. PubMed ID: 9817223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles.
    Puglia C; Esposito E; Menegatti E; Nastruzzi C; Rizza L; Cortesi R; Bonina F
    J Pharm Pharmacol; 2005 Sep; 57(9):1169-76. PubMed ID: 16105237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid radial transport of methyl nicotinate in the dermis.
    Guy RH; Maibach HI
    Arch Dermatol Res; 1982; 273(1-2):91-5. PubMed ID: 7184475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of benzyl nicotinate on the percutaneous absorption of dexamethasone in the rat.
    Kassem MA; Schulte KE
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):25-8. PubMed ID: 7389748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic measurement of percutaneous penetration enhancement in vivo.
    Ryatt KS; Stevenson JM; Maibach HI; Guy RH
    J Pharm Sci; 1986 Apr; 75(4):374-7. PubMed ID: 2941564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous penetration of methyl nicotinate from ointments using the laser Doppler technique: bioequivalence and enhancer effects.
    Remane Y; Leopold CS; Maibach HI
    J Pharmacokinet Pharmacodyn; 2006 Dec; 33(6):719-35. PubMed ID: 17006769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing a minimal erythema concentration of methyl nicotinate for optimum evaluation of anti-inflammatories.
    Jumbelic LC; Liebel FT; Southall MD
    Skin Pharmacol Physiol; 2006; 19(3):147-52. PubMed ID: 16612142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of some physical properties of four vehicles used in dermatological preparations.
    Baker BS; Fountain RB; Hadgraft JW; Sarkany I
    Br J Dermatol; 1969 Jan; 81(1):60-4. PubMed ID: 5763637
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide.
    Barrett CW; Hadgraft JW; Caron GA; Sarkany I
    Br J Dermatol; 1965 Nov; 77(11):576-8. PubMed ID: 5853251
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandin activity in sustained inflammation of human skin before and after aspirin.
    Plummer NA; Hensby CN; Black AK; Greaves MW
    Clin Sci Mol Med; 1977 Jun; 52(6):615-20. PubMed ID: 884933
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of calcium dobesilate upon thurfyl nicotinate erythema in man.
    Canal P; Erill S
    J Med; 1971; 2(6):375-9. PubMed ID: 5292128
    [No Abstract]   [Full Text] [Related]  

  • 20. Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat.
    Brattsand R; Harthon L
    Arzneimittelforschung; 1971 Sep; 21(9):1335-8. PubMed ID: 5171788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.